I now have comprehensive information to write a thorough answer. Let me compile it.
Bell's Palsy
Bell's palsy is the most common cause of acute unilateral facial paralysis. The name honors Sir Charles Bell, who first described the anatomy and function of the facial nerve.
Epidemiology
- Incidence: ~23-25 per 100,000 per year; approximately 1 in 60 persons over a lifetime
- Affects men and women roughly equally, at all ages
- Risk factors: diabetes mellitus, pregnancy (especially third trimester and first 2 weeks postpartum), and possibly hypertension
- Recurs in ~7-8% of cases, typically averaging 10 years between episodes
Anatomy Reminder
CN VII (facial nerve) supplies:
- Motor innervation to all muscles of facial expression and the scalp
- The stapedius muscle (sound dampening)
- Taste to the anterior 2/3 of the tongue (via chorda tympani)
- Parasympathetic fibers to lacrimal, submandibular, and sublingual glands
The nerve travels through the tight facial canal in the temporal bone - this anatomical constraint is central to why inflammation causes palsy.
Pathophysiology
Bell's palsy is a diagnosis of exclusion - "idiopathic" facial palsy. The dominant mechanism is:
- HSV-1 reactivation in the geniculate ganglion - HSV-1 DNA has been detected by PCR in endoneurial fluid surrounding CN VII in the majority of cases, and HSV inoculation in mice reproduces the syndrome
- VZV reactivation - accounts for up to one-third of cases (many without visible rash, distinguishing it from classic Ramsay Hunt)
- SARS-CoV-2 and HIV seroconversion have also been implicated
- Inflammation causes edema of the nerve within the rigid bony canal, producing compression ischemia
Clinical Manifestations
| Feature | Details |
|---|
| Onset | Acute; maximal weakness within 48 h (Harrison's) to 72 h (Tintinalli's) |
| Pain | Retroauricular pain 1-2 days before paralysis |
| Paralysis type | Lower motor neuron - weakness of BOTH upper and lower face (including frontalis), distinguishing it from central/UMN lesions |
| Taste | Impaired anterior 2/3 tongue (chorda tympani involvement) |
| Hyperacusis | Stapedius paralysis - sounds seem louder ipsilaterally |
| Lacrimation | May be reduced ipsilaterally |
| Numbness | Facial fullness/numbness reported subjectively; true sensory loss is rare |
Key bedside sign: In Bell's palsy, the patient cannot raise the eyebrow or close the eye on the affected side (LMN). In a stroke (UMN lesion), the forehead is spared because it receives bilateral cortical innervation.
Differential Diagnosis
These must be excluded before calling it Bell's palsy:
| Condition | Clue |
|---|
| Ramsay Hunt syndrome (VZV) | Vesicular rash in external auditory canal, pinna, palate; often more severe, worse prognosis |
| Lyme disease | Endemic area exposure, erythema migrans, can be bilateral; in endemic areas ≥10% of facial palsies |
| Sarcoidosis | Often bilateral; systemic features |
| Guillain-Barré syndrome | Bilateral facial palsy, ascending weakness, areflexia |
| Parotid/skull base tumor | Slowly progressive or recurrent palsy |
| HIV seroconversion | CSF pleocytosis present |
| Melkersson-Rosenthal | Recurrent facial palsy + facial edema + fissured tongue |
| Otitis media/cholesteatoma | Ear examination findings |
| Leprosy | Endemic areas, skin lesions |
Investigations
- MRI with gadolinium (fat-suppressed T1): Diffuse smooth linear enhancement of the facial nerve - geniculate ganglion, tympanic and mastoid segments - without a mass lesion (shown below). Note: similar enhancement can occur in Lyme, sarcoidosis, and perineural malignant spread, so it is supportive not diagnostic.
- EMG/NCS (after 10 days): Denervation potentials suggest axonal loss - predicts prolonged recovery over months; absence favors neurapraxia and good prognosis
- CSF: Mild lymphocytosis in a minority (not routinely sampled)
- Routine blood work: consider fasting glucose, Lyme serology (endemic areas), HIV if clinically indicated
Axial and coronal gadolinium-enhanced T1 MRI with fat suppression showing diffuse smooth linear enhancement of the facial nerve (genu, tympanic, and mastoid segments) - arrows. Highly suggestive of Bell's palsy but not pathognomonic. (Harrison's, Fig. 452-4)
Treatment
1. Corticosteroids (first-line, evidence-based)
- Prednisolone 25 mg twice daily for 10 days (Goldman-Cecil) or 40-60 mg/day for 10 days (Adams & Victor)
- Must be started early (within 72 hours of onset, ideally within 24-48 h)
- Increases complete recovery from ~63% to ~83% at 3 months
- Mechanism: reduces nerve edema within the tight facial canal
2. Antiviral agents (adjunct - selected cases)
- Acyclovir (400 mg 5x/day for 7 days) or Valacyclovir added to steroids
- Acyclovir alone provides no independent benefit
- Evidence is mixed: Sullivan trial did not support antivirals + steroids; Hato et al. found additive benefit of valacyclovir + prednisolone in patients with complete facial palsy
- Most guidelines offer antivirals as optional adjunct to steroids in moderate-severe cases
3. Eye protection
- Essential in complete palsy where eyelid closure is impaired
- Artificial tears during day; lubricating ointment + eye patch at night
- Prevents exposure keratopathy and corneal ulceration
4. No role for surgical decompression
- No evidence of benefit; may be harmful (Adams & Victor)
5. Physical therapy / rehabilitation
- Recent systematic reviews and meta-analyses (2024-2025) support physical therapy for peripheral facial palsy, particularly neuromuscular retraining and mime therapy
- Electrical stimulation in the acute stage remains controversial - a 2026 meta-analysis (PMID: 41167647) assessed its role
Prognosis
- ~70-80% recover completely within a few weeks to months
- ~85% achieve near-normal function
- ~10% have poor recovery
- Favorable signs:
- Incomplete paralysis in the first week
- Any motor recovery within 5-7 days
- Return of taste within the first week
- Unfavorable signs:
- Complete paralysis from onset
- EMG denervation after 10 days (axonal degeneration - recovery takes 3+ months via regeneration)
- Pronounced gadolinium enhancement on MRI
- Complications of aberrant regeneration:
- Synkinesis (involuntary co-movements, e.g., eye closure when chewing)
- Crocodile tears (tearing when eating - misdirected regeneration to lacrimal gland)
- "Jaw winking" (eye closure on jaw movement)
Summary Table
| Feature | Details |
|---|
| Nerve affected | CN VII (facial nerve) |
| Type of palsy | LMN - upper + lower face involved |
| Most common cause | HSV-1 reactivation |
| Incidence | 23-25/100,000/year |
| Key treatment | Prednisolone within 72 h |
| Recovery rate | ~80-85% |
| Recurrence | ~7-8% |
Sources: Harrison's Principles of Internal Medicine 22E, p. 3598 | Adams and Victor's Principles of Neurology 12E, p. 1371 | Goldman-Cecil Medicine | Tintinalli's Emergency Medicine
Recent evidence: Physical therapy meta-analyses (PMID
37149416, 2024) support neuromuscular rehabilitation. Electrical stimulation in acute Bell's palsy was reviewed in a 2026 meta-analysis (PMID
41167647) - findings are pending clinical integration. Core steroid and eye care management remains unchanged.